reported that NMO-IgG exacerbated the clinical course of EAE mice and induced NMOSD-like lesions including AQP4 and GFAP loss in the spinal cord, without observing the related pathologic changes in the optic nerve and brain. This evidence concerns the gene AQP4 and neuromyelitis optica.